Another week arises, which means new options trades I look forward to doing.
Teva Pharmaceutical Industries
$TEVA The FDA Approves Teva’s Generic Version of Mylan’s EpiPen, which is great news for the company and the fact it will help lower the cost of EpiPens to those who need it most. It is at a current price of $24.22 as of Friday 8/17/18. My target price is at $25.50 a share before Friday 8/24/18.
The Goldman Sachs Group, Inc.
$GS Faces Losses on Venezuelan Bond Deal which will decline the price of $GS temporary. Warren Buffet has also increased his holdings on Goldman Sachs on August 16th. With this roller coaster, I expect $GS target price to at $235.00 a share by 8/24/18 at its current price of $233.38 a share from Friday 8/17/18.
BIDU has decreased In the week Google announced its plan to have to search engine to enter the Chinese market. It scared shareholders of BIDU to drop in price. Although Google announced it will not be ready yet, I expect the stock to start recovering back up in price too $225 a share or higher by 8/24/18 from its price of $222.67 a share on Friday the 17th.